Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Uniqure Ord Shs (NQ: QURE ) 10.12 +3.45 (+51.72%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 10, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Uniqure Ord Shs < Previous 1 2 3 4 5 6 Next > Why Are UniQure Shares Surging Today? Today 16:00 EDT UniQure N.V. (NASDAQ: QURE) shares are skyrocketing Wednesday following the release of promising interim data from its Phase I/II clinical trials of AMT-130, a gene therapy targeting Huntington's... Via Benzinga Why SeaStar Medical Holding Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session Today 13:18 EDT Via Benzinga SMART Global Posts Upbeat Results, Joins Aehr Test Systems, MarineMax And Other Big Stocks Moving Higher On Wednesday Today 10:48 EDT Via Benzinga Recap: uniQure Q4 Earnings February 28, 2024 Via Benzinga Kura Sushi Posts Weak Q3 Results, Joins LegalZoom.com And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session Today 8:01 EDT Via Benzinga S&P 500 Edges Higher; Indivior Shares Plummet July 09, 2024 Via Benzinga Topics Stocks Exposures US Equities Why Helen of Troy Shares Are Trading Lower By Around 30%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session July 09, 2024 Via Benzinga Crude Oil Down 1%; Soligenix Shares Surge July 09, 2024 Via Benzinga Exposures Fossil Fuels Why UniQure Stock Is Soaring July 09, 2024 UniQure shares are trading higher Tuesday after the company announced updated interim data from its ongoing U.S. and European Phase I/II clinical trials of AMT-130 for the treatment of Huntington's... Via Benzinga MULN Stock Alert: Mullen Announces EV Sale to Spencer Manufacturing July 09, 2024 Mullen stock is down on Tuesday even as MULN shareholders learn of a new EV order for subsidiary Bollinger Motors from Spencer Manufacturing. Via InvestorPlace Why Is uniQure (QURE) Stock Up 51% Today? July 09, 2024 UniQure stock is up on Tuesday as QURE investors react to positive clinical trial data for its Huntington’s Disease treatment candidate. Via InvestorPlace Dow Falls Over 50 Points; US Small Business Optimism Surges In June July 09, 2024 Via Benzinga Topics Stocks Exposures US Equities uniQure Announces Positive Interim Data Update Demonstrating Slowing of Disease Progression in Phase I/II Trials of AMT-130 for Huntington’s Disease July 09, 2024 From uniQure Inc. Via GlobeNewswire uniQure Announces Sale of Commercial Manufacturing Facility to Genezen July 01, 2024 From uniQure Inc. Via GlobeNewswire uniQure Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Investigational Gene Therapy AMT-130 in Huntington’s Disease June 03, 2024 From uniQure Inc. Via GlobeNewswire QURE Stock Earnings: uniQure Misses EPS, Beats Revenue for Q1 2024 May 07, 2024 QURE stock results show that uniQure missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. Via InvestorPlace uniQure Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress May 07, 2024 From uniQure Inc. Via GlobeNewswire Pfizer Now Rivals The World's Most Expensive Medicine After FDA Approves Gene Therapy April 26, 2024 Pfizer won FDA approval for a new hemophilia B gene therapy, a rival to Hemgenix from CSL and Uniqure. Via Investor's Business Daily Exposures Product Safety AMD To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Monday March 04, 2024 Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Via Benzinga uniQure Announces 2023 Financial Results and Highlights Recent Company Progress February 28, 2024 From uniQure Inc. Via GlobeNewswire Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session February 29, 2024 Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed fourth-quarter financial results. Via Benzinga Why Compugen Shares Are Trading Higher By Over 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session December 19, 2023 Shares of Compugen Ltd. (NASDAQ: CGEN) shares rose sharply during Tuesday’s session after Gilead announced an agreement with the company to exclusively license its novel pre-clinical immunotherapy... Via Benzinga Bluebird Bio, Vertex Energy And Other Big Stocks Moving Lower On Tuesday December 19, 2023 U.S. stocks traded higher, with the Dow Jones index gaining around 150 points on Tuesday. Shares of bluebird bio, Inc. (NASDAQ: BLUE) shares fell sharply during Tuesday’s session after the company... Via Benzinga Topics Stocks Exposures US Equities uniQure Announces Update on Phase I/II Clinical Trials of AMT-130 Gene Therapy for the Treatment of Huntington’s Disease December 19, 2023 From uniQure Inc. Via GlobeNewswire uniQure Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) December 08, 2023 From uniQure Inc. Via GlobeNewswire uniQure Announces FDA Clearance of Investigational New Drug Application for AMT-191 Gene Therapy for Fabry Disease November 29, 2023 Patient enrollment expected to begin in first half of 2024 From uniQure Inc. Via GlobeNewswire 3 Micro-Cap Stocks That Could Be Moonshots November 14, 2023 If you are hungry for high-risk returns, then these micro-cap stocks to buy could be your winning ticket to future yields. Via InvestorPlace uniQure Announces Third Quarter 2023 Financial Results and Highlights Recent Company Progress November 07, 2023 From uniQure Inc. Via GlobeNewswire Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday November 02, 2023 Pre-market stock movers are a hot topic on Thursday and we're checking out all of the biggest ones worth watching this morning! Via InvestorPlace uniQure Announces Major Presence at the European Society of Gene and Cell Therapy (ESGCT) Annual Meeting October 24, 2023 From uniQure Inc. Via GlobeNewswire < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.